Atlas Trials

Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)

Clinical trial NCT01518153 · TERMINATED

Trial details

NCT number
NCT01518153
Sponsor
M.D. Anderson Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
LeukemiaLymphomaMyelomaMyeloproliferative Diseases
Start date
2012-02-01
Primary completion
2014-08-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.